Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University, Fuzhou, Fujian, PR China.
Crit Rev Microbiol. 2020 Nov;46(6):654-664. doi: 10.1080/1040841X.2020.1819771. Epub 2020 Sep 24.
Huperzine A (HupA) is an effective inhibitor of acetylcholinesterase and has attracted great interest as a therapeutic candidate for Alzheimer's disease. However, the use of HupA is limited by resource scarcity as well as by its low yields from its primary plant source. Recent studies have shown that this compound is produced by various endophytic fungi, thereby providing a promising alternative source, as fungi are much more amenable than plants owing to their simpler genetics and the ease of manipulation. In this review, we summarize the progress in research on the methods to increase HupA production, including fermentation conditions, fungal elicitors, gene expression, and the activation of key enzymes. This review provides guidance for further studies on HupA-producing endophytic fungi aimed at efficient HupA synthesis and accumulation, and offers new approaches for studies on the regulation of high-value bioactive secondary metabolites.
石杉碱甲(HupA)是一种有效的乙酰胆碱酯酶抑制剂,作为阿尔茨海默病的治疗候选药物引起了极大的关注。然而,由于资源稀缺以及其主要植物来源产量低,HupA 的使用受到限制。最近的研究表明,这种化合物是由各种内生真菌产生的,从而为其提供了一个很有前途的替代来源,因为真菌比植物更容易操作,这是由于真菌的遗传更简单,而且更容易操作。在这篇综述中,我们总结了提高 HupA 产量的方法的研究进展,包括发酵条件、真菌诱导剂、基因表达和关键酶的激活。这为进一步研究产 HupA 的内生真菌提供了指导,旨在实现 HupA 的高效合成和积累,并为研究高价值生物活性次生代谢物的调控提供了新的方法。